Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancerCentral MessagePerspective

Objective: To determine the frequency of pathogenic mutations in high-penetrance genes (HPGs) in patients with non–small cell lung cancer (NSCLC) and identify whether such mutations are associated with clinicopathologic outcomes. Methods: Patients with NSCLC who had consented to participate in a lin...

Full description

Bibliographic Details
Main Authors: Seth B. Krantz, MD, Kanwal Zeeshan, MBBS, Kristine M. Kuchta, MS, Thomas A. Hensing, MD, Kathy A. Mangold, PhD, S. Lilly Zheng, MD, Jianfeng Xu, MD, DrPH
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:JTCVS Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273622003515